Revvity (RVTY) Income from Continuing Operations (2009 - 2026)
Revvity's (RVTY) quarterly Income from Continuing Operations came in at 40893000.0 in Q2 2026, down 1.86% YoY from 41669000.0 in Q2 2025, and down 57.3% on a QoQ basis from 95771000.0 in Q4 2025.
Revvity (RVTY) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Income from Continuing Operations data on file, last reported at 40893000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 1.86% year-over-year to 40893000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 239107000.0 (down 19.23% YoY) and the FY2025 annual result came in at 239883000.0, down 15.26% from the prior year.
- Income from Continuing Operations retreated to 40893000.0 in Q2 2026, from 95771000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 299704000.0 in Q1 2022 to a low of 24845000.0 in Q2 2023.
- A 5-year average of 93675470.59 and a median of 69508000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations slumped 86.5% — and 2024, when it soared 187.62%.
- Tracing RVTY's Income from Continuing Operations over 5 years: stood at 69508000.0 in 2022, then slumped by 53.29% to 32469000.0 in 2023, then jumped by 172.21% to 88383000.0 in 2024, then climbed by 8.36% to 95771000.0 in 2025, then tumbled by 57.3% to 40893000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 40893000.0 (Q2 2026), 95771000.0 (Q4 2025), and 47221000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 53.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 53.48 Mn |
| Apr 5, 2026 | 40.89 Mn |
| Dec 28, 2025 | 95.77 Mn |
| Sep 28, 2025 | 47.22 Mn |
| Jun 29, 2025 | 55.22 Mn |
| Mar 30, 2025 | 41.67 Mn |
| Dec 29, 2024 | 88.38 Mn |
| Sep 29, 2024 | 93.39 Mn |
| Jun 30, 2024 | 72.61 Mn |
| Mar 31, 2024 | 28.70 Mn |
| Oct 1, 2023 | 32.47 Mn |
| Jul 2, 2023 | 58.62 Mn |
| Apr 2, 2023 | 24.85 Mn |
| Jan 1, 2023 | 197.82 Mn |
| Oct 2, 2022 | 69.51 Mn |
| Jul 3, 2022 | 161.60 Mn |
| Apr 3, 2022 | 184.07 Mn |
| Jan 2, 2022 | 299.70 Mn |
| Oct 3, 2021 | 107.63 Mn |
| Jul 4, 2021 | 221.24 Mn |